Abstract
Abstract Background Novel coronavirus disease 2019 (COVID-19) is associated with high mortality. Many laboratory values have been suggested to predict patients at risk for a poor outcome in COVID-19.The objective of this project was to systematically review and meta-analyze all laboratory markers associated with prognosis of mortality in patients with COVID-19. Methods We searched OVID Medline, SCOPUS, MedRxIv, preprints.org, and Centers for Disease Control databases from November 2019 to April 10, 2020 for articles on laboratory values and mortality in COVID-19 and updated the search July 20, 2020. Teams of 2 independent reviewers reviewed titles and abstracts for studies that reported mortality and laboratory values and subsequently abstracted relevant data. Results Our initial search identified 6,973 articles and a total of 96 articles (30 articles from first search and 66 from updated search) on 72 laboratory values were included. Many laboratory values were associated with mortality, but those most associated with mortality included lymphopenia (OR 0.30, 95% CI 0.24-0.36), thrombocytopenia (OR 0.46, 95% CI 0.35-0.60), elevated lactate dehydrogenase (OR 7.32, 95% CI 5.19-10.33), and ferritinemia (OR 5.19, 95% CI 3.07-8.62). All cardiac markers were associated with mortality, with troponin being the least associated. A low PaO2:FiO2 ratio was also associated with mortality (OR 0.13, 95% CI -0.06-0.28). Heterogeneity was high and risk of bias was moderate. Conclusions This meta-analysis identified many laboratory abnormalities associated with mortality in COVID-19, though was limited by heterogeneity. Laboratory markers previously identified as associated with a poor prognosis in COVID-19 were confirmed to be those most associated with mortality in this large meta-analysis.
Highlights
Novel coronavirus disease 2019 (COVID-19) has caused over a million international deaths and overwhelmed healthcare systems internationally: Wuhan, China; Lombardy, Italy; and New York City, New York
The search was updated on July 20, 2020 with a focused search in PubMed and MedRxIV, using the laboratory values found in the initial search
Our initial search identified 6,973 unique articles. 147 of these were identified for full text review, and 30 were deemed to meet all inclusion and no exclusion criteria (Figure 1)
Summary
Novel coronavirus disease 2019 (COVID-19) has caused over a million international deaths and overwhelmed healthcare systems internationally: Wuhan, China; Lombardy, Italy; and New York City, New York. This disease has led to overall mortality rates from 1-6%, [1-3] with the subset of patients who require critical care or intubation having mortality as high as 50-80% [4,5]. A small percentage of patients will require hospitalization for aggressive supportive care - supplemental oxygen, intubation, and sometimes cardiac support [7] Those at most risk for severe outcomes appear to be the obese, [8] the elderly, [3] and those with prior heart or lung disease [9]. Many laboratory values have been suggested to predict patients at risk for a poor outcome in COVID-19.The objective of this project was to systematically review and meta-analyze all laboratory markers associated with prognosis of mortality in patients with COVID-19
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Scholarly Journal of Emergency Medicine and Critical Care
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
